Literature DB >> 3931788

Malignant hypercalcaemia.

A K Bhalla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3931788      PMCID： PMC1416926          DOI： 10.1136/bmj.291.6501.1049-c

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  7 in total

1.  Tumor products and the hypercalcemia of malignancy.

Authors:  G R Mundy; K J Ibbotson; S M D'Souza
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

2.  Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma.

Authors:  N A Breslau; J L McGuire; J E Zerwekh; E P Frenkel; C Y Pak
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

3.  Abnormal vitamin D metabolism in Hodgkin's lymphoma.

Authors:  M Davies; E B Mawer; M E Hayes; G A Lumb
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

4.  Leiomyoblastoma associated with intractable hypercalcemia and elevated 1,25-dihydroxycholecalciferol levels. Treatment by hepatic enzyme induction.

Authors:  M Maislos; R Sobel; S Shany
Journal:  Arch Intern Med       Date:  1985-03

5.  Humoral hypercalcemia in Hodgkin's disease. Association with elevated 1,25-dihydroxycholecalciferol levels and subperiosteal bone resorption.

Authors:  G P Zaloga; C Eil; C A Medbery
Journal:  Arch Intern Med       Date:  1985-01

6.  Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.

Authors:  J S Adams; O P Sharma; M A Gacad; F R Singer
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

7.  Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia.

Authors:  N Rosenthal; K L Insogna; J W Godsall; L Smaldone; J A Waldron; A F Stewart
Journal:  J Clin Endocrinol Metab       Date:  1985-01       Impact factor: 5.958
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.